Redefining breast cancer subtypes to guide treatment prioritization and maximize response: Predictive biomarkers across 10 cancer therapiesDenise M. Wolf, Laura van ‘t Veer, Rosa I. Gallagher et al.|Cancer Cell|2022Cited by 335
Protein signaling and drug target activation signatures to guide therapy prioritization: Therapeutic resistance and sensitivity in the I-SPY 2 TrialRosa I. Gallagher, Emanuel F. Petricoin, Julia Wulfkuhle et al.|Cell Reports Medicine|2023Cited by 18